Clinical Trials in Michigan

Showing 7821-7840 of 16,154 trials

Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

NCT05378711

The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective mutism symptomology.

Selective MutismSocial Anxiety

Michigan State University6 participantsStarted Jan 2014

East Lansing, Michigan, United States

COMPLETEDPhase 441 miles

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

NCT03288129

This study will assess the retention rate of perampanel when given as monotherapy or first adjunctive therapy in participants with partial-onset seizures or primary generalized tonic clonic seizures. The study consists of 4 periods: a Screening Period (to start no earlier than 6 weeks before the first dose of study drug), a Titration Period (up to 13 weeks), a Maintenance Period (39 weeks), and a Follow-Up Period (4 weeks).

Partial Onset SeizuresSecondarily Generalized SeizuresPrimary Generalized Tonic-Clonic Seizures

Eisai Inc.54 participantsStarted Aug 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +21 more locations

Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Find Trials by Condition in Michigan

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Struvite Stones Antibiotic Study

EndoPredict® Extended Endocrine Trial (EXET)

LithoVue Single Use Disposable Ureteroscope

Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Stretching and Musculoskeletal Pain

The TOGETHER Project - Liver

Objective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endometriosis